PharmiWeb.com - Global Pharma News & Resources
25-Aug-2023

Defibrillator Market Trends 2023: A High Potential for Growth Expected to Register a CAGR of 6.6% by 2030

The global defibrillator market size was valued at $13,168 million in 2020, and is projected to reach $24,608.3 million by 2030, registering a CAGR of 6.6% from 2021 to 2030.

Defibrillators Market by Product (Implantable Defibrillators and External Defibrillators) and End User (Hospital, Pre Hospital, Public Access Market, Alternative Care, and Home): Global Opportunity Analysis and Industry Forecast 2021-2030

The global Defibrillators Market report summarizes market developments, competitor analysis, and future market and technological predictions. The report also assists the major market players in increasing their market share and maintaining their competitive position in the sector. It does this by highlighting the global Defibrillators Market from 2021 to 2030.

Additionally, it offers a qualitative analysis of a range of factors, such as the strategies employed by significant rivals, implicit possibilities, immediate impact on market size, regulatory framework, and economic influence. Significant investments are also included in the market research, on which stakeholders can base their CAGR and relative Defibrillators Market
shares.

Sample Copy of the Report: 

https://www.alliedmarketresearch.com/request-sample/1434

Focus on installation of public access defibrillator (PAD) by the public and private organizations, development of advanced defibrillator devices, and increase in incidence of cardiac diseases drive the growth of the global defibrillator market. Moreover, rise in adoption of technologically advanced defibrillator devices and rise in demand for quality medical care supplement the growth. However, surge in pricing pressure on market players restrains the market growth. On the other hand, advancements in the next-generation external defibrillators to improve safety and effectiveness present new opportunities in the coming years.

Market Segmentation:

Product Type:

a. Automated External Defibrillators (AEDs): Portable devices designed for use by non-medical personnel in public settings.

b. Implantable Cardioverter Defibrillators (ICDs): Surgically implanted devices that continuously monitor heart rhythms and deliver therapy when necessary.

c. Wearable Defibrillators: External devices worn by patients at risk of sudden cardiac arrest, providing continuous monitoring and immediate defibrillation if needed.

d. Manual External Defibrillators: Traditional defibrillators used by trained healthcare professionals in clinical settings.

End User:

a. Hospitals: Defibrillators used in hospital settings, including emergency departments, intensive care units, and operating rooms.

b. Pre-hospital Care: Defibrillators used by emergency medical services (EMS) providers, paramedics, and first responders in ambulances and other pre-hospital settings.

c. Public Access: Defibrillators placed in public spaces, such as airports, shopping malls, sports arenas, and schools, for immediate use by bystanders during cardiac emergencies.

Technology:

a. Manual Defibrillators: Traditional defibrillators that require trained healthcare professionals to manually analyze heart rhythms and deliver shocks.

b. Automated Defibrillators: Defibrillators with built-in algorithms that automatically analyze heart rhythms and deliver shocks if necessary. This includes AEDs and ICDs.

Geography:

The market can also be segmented based on geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each region may have specific market dynamics, regulatory frameworks, and adoption rates.

Application:

Defibrillators can be segmented based on their applications, including cardiac arrest, arrhythmias, ischemic heart disease, heart failure, and others.

Distribution Channel:

a. Direct Sales: Manufacturers selling defibrillators directly to healthcare facilities, EMS providers, and other end users.

b. Distributors: Defibrillators distributed through authorized distributors who supply to hospitals, clinics, and other healthcare institutions.

These are some common segmentation approaches, but it’s important to note that the actual segmentation can vary based on specific market research studies and industry reports.

Request for Customization – https://www.alliedmarketresearch.com/request-for-customization/1434

Research Methodology

The research operandi of the global Defibrillators Market includes significant primary as well as secondary research. When the primary methodology encompasses widespread discussion with a plethora of valued participants, the secondary research involves a substantial amount of product/service descriptions. Furthermore, several government sites, industry bulletins, and press releases have also been properly examined to bring forth high-value industry insights.

Key Findings Of The Study

  • By product, the implantable defibrillators segment was the highest contributor to the market in 2020.
  • Depending on end user, the hospital segment led the market in 2020.
  • Region wise, North America garnered the largest revenue share in 2020. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Regional Growth Dynamics:

North America garnered a major share of the electrophysiology market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of cardiac arrhythmia, increase in number of geriatric population, and strong presence of key players. However, Asia-Pacific is expected to register highest CAGR of 8.2% from 2021 to 2030, owing to increase in prevalence of atrial fibrillation, advancements in technology in the field of defibrillator, and initiatives taken by governments to enhance healthcare infrastructure

Competitive Landscape:

  • Medtronic plc
  • Philips Healthcare (a division of Royal Philips)
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation)
  • Stryker Corporation
  • Physio-Control (a subsidiary of Stryker Corporation)
  • Cardiac Science Corporation (a subsidiary of Opto Circuits Limited)
  • Nihon Kohden Corporation
  • LivaNova plc

Procure Complete Report at 20% Discount (258 Pages) : 

https://www.alliedmarketresearch.com/purchase-enquiry/1434

Related Reports :

Plasma Therapy Market: https://www.alliedmarketresearch.com/plasma-therapy-market-A13680

Hematology Analyzers market: https://www.alliedmarketresearch.com/hematology-analyzer-market-A13630

veterinary artificial reproduction market: https://www.alliedmarketresearch.com/veterinary-artificial-reproduction-market-A13676

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Editor Details

  • Company:
    • The Wire Times
Last Updated: 25-Aug-2023